Resultados de la búsqueda 331-340 of 9628 for monoclonal antibody

1. Hematología - Ensayos clínicos

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

2. Oncología (médica) - Ensayos clínicos

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

3. Hematología - Ensayos clínicos

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

4. Hematología - Ensayos clínicos

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

5. Hematología - Ensayos clínicos

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

6. Hematología - Ensayos clínicos

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving acalabrutinib ...

7. Cirugía - Ensayos clínicos - Mayo Clinic

   Tumors with high number of mutations may respond well to immunotherapy. Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the ...

8. Hematología - Ensayos clínicos

   Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a type of chemotherapy called calicheamicin. ... * Whether the body makes antibodies ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

10. Oncología (médica) - Ensayos clínicos

    Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...